Characteristics and Problems of Rheumatic Heart Disease in Indonesia: The Ina-RHD Multicenter Study

Amiliana Mardiani Soesanto1, Prima Almazini2, Rina Ariani1

  • 1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Center Harapan Kita, Jakarta, Indonesia.

JACC. Asia
|May 14, 2025
PubMed

Insights

This study highlights the significant burden of Rheumatic Heart Disease (RHD) in Indonesia, predominantly affecting women with mitral stenosis and advanced disease. Management challenges include underutilization of anticoagulation and secondary prophylaxis.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Rheumatic Heart Disease (RHD) poses a significant public health challenge globally.
  • Indonesia lacks comprehensive national data on RHD incidence and prevalence.

Purpose of the Study:

  • To characterize the demographics, clinical presentation, and management of RHD patients in Indonesia.
  • To identify the burdens and challenges associated with RHD care in the Indonesian context.

Main Methods:

  • Retrospective analysis of medical records from 3,431 RHD patients aged over 18 across 21 Indonesian hospitals.
  • Collection of clinical and echocardiography data to assess disease characteristics, severity, and complications.

Main Results:

  • The study population (average age 44) was predominantly female (64.4%). Isolated mitral stenosis was the most common valve lesion (39.6%). High rates of dyspnea (85.7%), atrial fibrillation (62.5%), and stroke history (6.6%) were observed.
  • Pulmonary hypertension and right heart involvement were common, with many patients presenting at advanced NYHA functional class (III-IV) in 25% of cases.
  • Suboptimal anticoagulation use (70.3% prescribed Vitamin K antagonist) and underuse of secondary prophylaxis (37.3% administered, 23.2% regularly) were identified.

Conclusions:

  • RHD in Indonesia disproportionately affects women and is often diagnosed at later stages.
  • High prevalence of atrial fibrillation and valve lesions like mitral stenosis necessitate improved anticoagulation strategies.
  • Underutilization of secondary prophylaxis represents a critical gap in RHD management, increasing the risk of recurrent rheumatic fever and complications.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Heart Valves01:17

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
3.9K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K
Imbalances in Cardiac Output01:23

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
321